Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

SMART TRENDS Study

NCT: NCT05957406 · COMPLETED

NCT IDNCT05957406

StatusCOMPLETED

Start Date2023-07-11

Completion2025-10-27

SponsorBecton, Dickinson and Company (INDUSTRY)

First posted2023-07-24

Last updated2026-07-08

Brief Summary

A multicenter, interventional, feasibility comparison with historical controls

Frequently Asked Questions

What is SMART TRENDS Study?

SMART TRENDS Study is a clinical trial registered under NCT05957406. Current status: COMPLETED.

What is the status of NCT05957406?

The current status of NCT05957406 (SMART TRENDS Study) is: COMPLETED.

When did SMART TRENDS Study start?

SMART TRENDS Study started on 2023-07-11.

Related Devices

K151320BD Phoenix Automated Microbiology System-Ertapenem 0.0625-8 mcg/mlBecton, Dickinson and Company K151589BD MAX CT/GC/TV, BD MAX INSTRUMENTBecton, Dickinson and Company K151866BD BACTEC Peds Plus/F Culture Vials (plastic)Becton, Dickinson and Company K151870BD U-500 INSULIN SYRINGEBecton, Dickinson and Company K153309BD Vacutainer UltraTouch Push Button Blood Collection SetBecton, Dickinson and Company

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑